125 related articles for article (PubMed ID: 2805962)
1. [The clinical significance of anti-RNP antibody].
Tang FL; Dong Y; Zhang NZ
Zhonghua Nei Ke Za Zhi; 1989 Apr; 28(4):229-31, 252. PubMed ID: 2805962
[TBL] [Abstract][Full Text] [Related]
2. Clinical course of patients with anti-RNP antibodies. A prospective study of 32 patients.
Lundberg I; Hedfors E
J Rheumatol; 1991 Oct; 18(10):1511-9. PubMed ID: 1765975
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of anti-RNP and anti-Sm autoantibodies as determined by immunoblotting and immunoprecipitation in sera from patients with connective tissue diseases.
Combe B; Rucheton M; Graafland H; Lussiez V; Brunel C; Sany J
Clin Exp Immunol; 1989 Jan; 75(1):18-24. PubMed ID: 2702772
[TBL] [Abstract][Full Text] [Related]
4. Differentiation of RNP- and SM-antibody subsets in SLE and MCTD patients by a new ELISA using recombinant antigens.
Gaubitz M; Wegmann C; Schotte H; Willeke P; Domschke W
Cell Mol Biol (Noisy-le-grand); 2002 May; 48(3):317-21. PubMed ID: 12030437
[TBL] [Abstract][Full Text] [Related]
5. Clinical course of patients with anti-RNP antibodies.
Snowden N; Hay E; Holt PJ; Bernstein R
J Rheumatol; 1993 Jul; 20(7):1256-8. PubMed ID: 8371236
[No Abstract] [Full Text] [Related]
6. [Clinical features and laboratory findings in children with both anti-dsDNA and anti-U1-RNP antibody].
Miyamae T; Ito S; Machida H; Ozawa R; Higuchi R; Nakajima S; Imagawa T; Nakamura T; Mori M; Aihara Y; Ohshige K; Yokota S
Nihon Rinsho Meneki Gakkai Kaishi; 2008 Oct; 31(5):405-14. PubMed ID: 18974625
[TBL] [Abstract][Full Text] [Related]
7. Quantitative radioligand assays using de novo-synthesized recombinant autoantigens in connective tissue diseases: new tools to approach the pathogenic significance of anti-RNP antibodies in rheumatic diseases.
Yamamoto AM; Amoura Z; Johannet C; Jeronimo AL; Campos H; Koutouzov S; Piette JC; Bach JF
Arthritis Rheum; 2000 Mar; 43(3):689-98. PubMed ID: 10728764
[TBL] [Abstract][Full Text] [Related]
8. Comparison between 3 diagnostic criteria for mixed connective tissue disease. Study of 593 patients.
Alarcón-Segovia D; Cardiel MH
J Rheumatol; 1989 Mar; 16(3):328-34. PubMed ID: 2724251
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis and risk stratification in patients with anti-RNP autoimmunity.
Carpintero MF; Martinez L; Fernandez I; Romero AC; Mejia C; Zang YJ; Hoffman RW; Greidinger EL
Lupus; 2015 Sep; 24(10):1057-66. PubMed ID: 25736140
[TBL] [Abstract][Full Text] [Related]
10. Clinical usefulness of antibodies to U1snRNP proteins in mixed connective tissue disease and systemic lupus erythematosus.
Margaux J; Hayem G; Palazzo E; Chazerain P; De Bandt M; Haim T; Kahn MF; Meyer O
Rev Rhum Engl Ed; 1998 Jun; 65(6):378-86. PubMed ID: 9670329
[TBL] [Abstract][Full Text] [Related]
11. Clinical manifestations and anti-(U1)snRNP antibodies: a prospective study of 29 anti-RNP antibody positive patients.
Lundberg I; Nyman U; Pettersson I; Hedfors E
Br J Rheumatol; 1992 Dec; 31(12):811-7. PubMed ID: 1458287
[TBL] [Abstract][Full Text] [Related]
12. High serum levels of antibodies against the recombinant 70 kDa ribonucleoprotein are useful for diagnosing mixed connective tissue disease.
Salmhofer W; Hermann J; Joch M; Kerl H; Graninger W
J Eur Acad Dermatol Venereol; 2007 Sep; 21(8):1047-53. PubMed ID: 17714123
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcome in mixed connective tissue disease: longitudinal clinical and serologic findings.
Burdt MA; Hoffman RW; Deutscher SL; Wang GS; Johnson JC; Sharp GC
Arthritis Rheum; 1999 May; 42(5):899-909. PubMed ID: 10323445
[TBL] [Abstract][Full Text] [Related]
14. Serial estimation of anti-RNP antibody titers in systemic lupus erythematosus, mixed connective tissue disease and rheumatoid arthritis.
Nishikai M; Okano Y; Mukohda Y; Sato A; Ito M
J Clin Lab Immunol; 1984 Jan; 13(1):15-9. PubMed ID: 6609234
[TBL] [Abstract][Full Text] [Related]
15. Assays for Sm and RNP antibodies: pitfalls and technical considerations.
Molden DP; Suzuki H; Nakamura RM
Diagn Immunol; 1985; 3(1):24-8. PubMed ID: 3922661
[TBL] [Abstract][Full Text] [Related]
16. Identification of anti-Sm and anti-RNP autoantibodies by immunoblotting and immunoassay.
Zurgil N; Shafrir S; Slor H; Shoenfeld Y
Isr J Med Sci; 1988 Dec; 24(12):751-4. PubMed ID: 3225188
[No Abstract] [Full Text] [Related]
17. A murine model of mixed connective tissue disease induced with U1 small nuclear RNP autoantigen.
Greidinger EL; Zang Y; Jaimes K; Hogenmiller S; Nassiri M; Bejarano P; Barber GN; Hoffman RW
Arthritis Rheum; 2006 Feb; 54(2):661-9. PubMed ID: 16453294
[TBL] [Abstract][Full Text] [Related]
18. Quantitation of anti-RNP and anti-Sm antibodies in MCTD and SLE patients by immunoblotting.
Habets WJ; de Rooij DJ; Hoet MH; van de Putte LB; van Venrooij WJ
Clin Exp Immunol; 1985 Feb; 59(2):457-66. PubMed ID: 3884199
[TBL] [Abstract][Full Text] [Related]
19. The impact of anti-U1-RNP positivity: systemic lupus erythematosus versus mixed connective tissue disease.
Dima A; Jurcut C; Baicus C
Rheumatol Int; 2018 Jul; 38(7):1169-1178. PubMed ID: 29796907
[TBL] [Abstract][Full Text] [Related]
20. Blotting patterns of IgG anti-(U1)RNP antibodies in mixed connective tissue disease.
Ghirardello A; Doria A; Vesco P; Vaccaro E; Bernardi C; Catani C; Fagiolo U; Gambari PF
Rheumatol Int; 1996; 16(4):145-50. PubMed ID: 8961378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]